Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1998 Mar;64(3):306–313. doi: 10.1136/jnnp.64.3.306

A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?

P Talbot 1, J Lloyd 1, J Snowden 1, D Neary 1, H Testa 1
PMCID: PMC2169991  PMID: 9527139

Abstract

OBJECTIVES—To provide the clinician with a guide to the clinical utility of 99mTc-HMPAO single photon emission computed tomography (SPECT) and to the interpretation of specific test results in the differential diagnosis of dementia.
METHODS—Three hundred and sixty three patients with dementia were studied prospectively for a median three (range 1-6) years and classified into disease groups on the basis of established clinical criteria. The degree to which different patterns of cerebral blood flow (CBF) abnormality found on 99mTc-HMPAO SPECT imaging at the time of initial patient presentation modified clinical diagnoses was determined by calculating the likelihood ratios for pairwise disease group comparisons. The optimal clinical usage of 99mTc-HMPAO SPECT was determined by calculating the percentage of significant test results for each pairwise disease group comparison.
RESULTS—Bilateral posterior CBF abnormality was found to significantly increase the odds of a patient having Alzheimer's disease as opposed to vascular dementia or frontotemporal dementia. Bilateral anterior CBF abnormality significantly increased the odds of a patient having frontotemporal dementia as opposed to Alzheimer's disease, vascular dementia, or Lewy body disease. "Patchy" CBF changes significantly increased the odds of a patient having vascular dementia as opposed to Alzheimer's disease. Unilateral anterior, unilateral anterior plus unilateral posterior, and generalised CBF abnormality failed to contribute to the differentiation of any of these forms of dementia.
CONCLUSIONS—99mTc-HMPAO SPECT was found to be most useful in distinguishing Alzheimer's disease from vascular dementia and fronto temporal dementia, and least useful in differentiating between Alzheimer's disease and Lewy body disease, and between vascular dementia, frontotemporal dementia, and progressive aphasia. It is suggested that CBF SPECT should be used selectively and as an adjunct to clinical evaluation and CT.



Full Text

The Full Text of this article is available as a PDF (157.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkett N. J. Evaluation of diagnostic tests with multiple diagnostic categories. J Clin Epidemiol. 1988;41(5):491–494. doi: 10.1016/0895-4356(88)90051-0. [DOI] [PubMed] [Google Scholar]
  2. Black W. C., Armstrong P. Communicating the significance of radiologic test results: the likelihood ratio. AJR Am J Roentgenol. 1986 Dec;147(6):1313–1318. doi: 10.2214/ajr.147.6.1313. [DOI] [PubMed] [Google Scholar]
  3. Burns A., Philpot M. P., Costa D. C., Ell P. J., Levy R. The investigation of Alzheimer's disease with single photon emission tomography. J Neurol Neurosurg Psychiatry. 1989 Feb;52(2):248–253. doi: 10.1136/jnnp.52.2.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caselli R. J., Jack C. R., Jr Asymmetric cortical degeneration syndromes. A proposed clinical classification. Arch Neurol. 1992 Jul;49(7):770–780. doi: 10.1001/archneur.1992.00530310118022. [DOI] [PubMed] [Google Scholar]
  5. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):416–418. doi: 10.1136/jnnp.57.4.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cummings J. L., Benson D. F. Subcortical dementia. Review of an emerging concept. Arch Neurol. 1984 Aug;41(8):874–879. doi: 10.1001/archneur.1984.04050190080019. [DOI] [PubMed] [Google Scholar]
  7. Ell P. J. Single photon emission computed tomography (SPET) of the brain. J Neurosci Methods. 1990 Sep;34(1-3):207–217. doi: 10.1016/0165-0270(90)90060-s. [DOI] [PubMed] [Google Scholar]
  8. Gustafson L. Clinical picture of frontal lobe degeneration of non-Alzheimer type. Dementia. 1993 May-Aug;4(3-4):143–148. doi: 10.1159/000107313. [DOI] [PubMed] [Google Scholar]
  9. Habert M. O., Spampinato U., Mas J. L., Piketty M. L., Bourdel M. C., de Recondo J., Rondot P., Askienazy S. A comparative technetium 99m hexamethylpropylene amine oxime SPET study in different types of dementia. Eur J Nucl Med. 1991;18(1):3–11. doi: 10.1007/BF00177677. [DOI] [PubMed] [Google Scholar]
  10. Holman B. L., Johnson K. A., Gerada B., Carvalho P. A., Satlin A. The scintigraphic appearance of Alzheimer's disease: a prospective study using technetium-99m-HMPAO SPECT. J Nucl Med. 1992 Feb;33(2):181–185. [PubMed] [Google Scholar]
  11. Kerwin R. Functional neuroimaging in Alzheimer's disease: how far should we go? Eur J Nucl Med. 1994 Oct;21(10):1041–1043. doi: 10.1007/BF00181057. [DOI] [PubMed] [Google Scholar]
  12. Kouris K., Jarritt P. H., Costa D. C., Ell P. J. Physical assessment of the GE/CGR Neurocam and comparison with a single rotating gamma-camera. Eur J Nucl Med. 1992;19(4):236–242. doi: 10.1007/BF00175135. [DOI] [PubMed] [Google Scholar]
  13. Mann D. M., Snowden J. S. The topographic distribution of brain atrophy in cortical Lewy body disease: comparison with Alzheimer's disease. Acta Neuropathol. 1995;89(2):178–183. doi: 10.1007/BF00296363. [DOI] [PubMed] [Google Scholar]
  14. Mann D. M., South P. W. The topographic distribution of brain atrophy in frontal lobe dementia. Acta Neuropathol. 1993;85(3):334–340. doi: 10.1007/BF00227731. [DOI] [PubMed] [Google Scholar]
  15. Mann D. M. The topographic distribution of brain atrophy in Alzheimer's disease. Acta Neuropathol. 1991;83(1):81–86. doi: 10.1007/BF00294434. [DOI] [PubMed] [Google Scholar]
  16. McKeith I. G., Bartholomew P. H., Irvine E. M., Cook J., Adams R., Simpson A. E. Single photon emission computerised tomography in elderly patients with Alzheimer's disease and multi-infarct dementia. Regional uptake of technetium-labelled HMPAO related to clinical measurements. Br J Psychiatry. 1993 Nov;163:597–603. doi: 10.1192/bjp.163.5.597. [DOI] [PubMed] [Google Scholar]
  17. McKeith I. G., Perry R. H., Fairbairn A. F., Jabeen S., Perry E. K. Operational criteria for senile dementia of Lewy body type (SDLT). Psychol Med. 1992 Nov;22(4):911–922. doi: 10.1017/s0033291700038484. [DOI] [PubMed] [Google Scholar]
  18. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  19. Miller B. L., Cummings J. L., Villanueva-Meyer J., Boone K., Mehringer C. M., Lesser I. M., Mena I. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology. 1991 Sep;41(9):1374–1382. doi: 10.1212/wnl.41.9.1374. [DOI] [PubMed] [Google Scholar]
  20. Montaldi D., Brooks D. N., McColl J. H., Wyper D., Patterson J., Barron E., McCulloch J. Measurements of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1990 Jan;53(1):33–38. doi: 10.1136/jnnp.53.1.33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Neary D., Snowden J. S., Bowen D. M., Sims N. R., Mann D. M., Benton J. S., Northen B., Yates P. O., Davison A. N. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry. 1986 Feb;49(2):163–174. doi: 10.1136/jnnp.49.2.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Neary D., Snowden J. S., Mann D. M. Familial progressive aphasia: its relationship to other forms of lobar atrophy. J Neurol Neurosurg Psychiatry. 1993 Oct;56(10):1122–1125. doi: 10.1136/jnnp.56.10.1122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Neary D., Snowden J. S., Northen B., Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry. 1988 Mar;51(3):353–361. doi: 10.1136/jnnp.51.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Neary D., Snowden J. S., Shields R. A., Burjan A. W., Northen B., MacDermott N., Prescott M. C., Testa H. J. Single photon emission tomography using 99mTc-HM-PAO in the investigation of dementia. J Neurol Neurosurg Psychiatry. 1987 Sep;50(9):1101–1109. doi: 10.1136/jnnp.50.9.1101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Read S. L., Miller B. L., Mena I., Kim R., Itabashi H., Darby A. SPECT in dementia: clinical and pathological correlation. J Am Geriatr Soc. 1995 Nov;43(11):1243–1247. doi: 10.1111/j.1532-5415.1995.tb07400.x. [DOI] [PubMed] [Google Scholar]
  26. Román G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J. M., Brun A., Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250–260. doi: 10.1212/wnl.43.2.250. [DOI] [PubMed] [Google Scholar]
  27. Saris S. C., Wright D. C., Oldfield E. H., Blasberg R. G. Intravascular streaming and variable delivery to brain following carotid artery infusions in the Sprague-Dawley rat. J Cereb Blood Flow Metab. 1988 Feb;8(1):116–120. doi: 10.1038/jcbfm.1988.15. [DOI] [PubMed] [Google Scholar]
  28. Snowden J. S., Neary D., Mann D. M., Goulding P. J., Testa H. J. Progressive language disorder due to lobar atrophy. Ann Neurol. 1992 Feb;31(2):174–183. doi: 10.1002/ana.410310208. [DOI] [PubMed] [Google Scholar]
  29. Starkstein S. E., Migliorelli R., Tesón A., Sabe L., Vázquez S., Turjanski M., Robinson R. G., Leiguarda R. Specificity of changes in cerebral blood flow in patients with frontal lobe dementia. J Neurol Neurosurg Psychiatry. 1994 Jul;57(7):790–796. doi: 10.1136/jnnp.57.7.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Talbot P. R., Goulding P. J., Lloyd J. J., Snowden J. S., Neary D., Testa H. J. Inter-relation between "classic" motor neuron disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. J Neurol Neurosurg Psychiatry. 1995 May;58(5):541–547. doi: 10.1136/jnnp.58.5.541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Talbot P. R., Snowden J. S., Lloyd J. J., Neary D., Testa H. J. The contribution of single photon emission tomography to the clinical differentiation of degenerative cortical brain disorders. J Neurol. 1995 Sep;242(9):579–586. doi: 10.1007/BF00868810. [DOI] [PubMed] [Google Scholar]
  32. Talbot P. R., Testa H. J. The value of SPET imaging in dementia. Nucl Med Commun. 1995 Jun;16(6):425–437. doi: 10.1097/00006231-199506000-00002. [DOI] [PubMed] [Google Scholar]
  33. Varma A. R., Talbot P. R., Snowden J. S., Lloyd J. J., Testa H. J., Neary D. A 99mTc-HMPAO single-photon emission computed tomography study of Lewy body disease. J Neurol. 1997 Jun;244(6):349–359. doi: 10.1007/s004150050101. [DOI] [PubMed] [Google Scholar]
  34. Waldemar G. Functional brain imaging with SPECT in normal aging and dementia. Methodological, pathophysiological, and diagnostic aspects. Cerebrovasc Brain Metab Rev. 1995 Summer;7(2):89–130. [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES